ProKidney Corp.
PROK
$1.33
-$0.08-5.34%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/14/2026
-
SeekingAlpha
8/14/2026
-
Seeking Alpha - Healthcare
8/13/2026
-
TipRanks
8/13/2026
-
MarketBeat
8/12/2026
-
MarketBeat
8/11/2026
-
TipRanks
8/11/2026
-
TipRanks
8/11/2026
-
TipRanks
8/10/2026
-
Zacks Investment Research
8/10/2026
-
TipRanks: TheFly
8/10/2026
-
MarketBeat
8/4/2026
-
MarketBeat
7/4/2026
-
The Cerbat Gem
6/26/2026
-
The Cerbat Gem
6/22/2026
-
The Cerbat Gem
6/17/2026
-
Insider Monkey
6/2/2026
-
Globe Newswire
5/21/2026
-
The Cerbat Gem
5/19/2026
-
The Cerbat Gem
5/18/2026
-
The Cerbat Gem
5/18/2026
-
TipRanks Financial Blog
5/18/2026
-
SeekingAlpha.com: All News
5/17/2026
-
TipRanks Financial Blog
5/15/2026
-
Zacks Investment Research
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
336 999 7019
Address
2000 Frontis Plaza Boulevard
Suite 250
Winston-Salem, NC 27103
Suite 250
Winston-Salem, NC 27103
Country
Year Founded
Business Description
Sector
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops...
more